27 results
F-1/A
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
, consistent with applicable laws and the Company’s need to investigate your concern. As noted under “Review and Investigation of Accounting Complaints” herein … of employment. All persons who are interviewed, asked to provide information or otherwise participate in an investigation have a duty to fully
F-1
EX-99.2
CNTB
Connect Biopharma Holdings Ltd
26 Feb 21
Registration statement (foreign)
4:56pm
, or investigation before or brought by any Governmental Agency against any of the PRC Companies on labor or employment matters, except, in each case, for those … qualifications (the “Qualifications”):
Our opinions are limited to PRC Laws of general application on the date hereof. We have made no investigation
F-1/A
EX-99.2
CNTB
Connect Biopharma Holdings Ltd
17 Mar 21
Registration statement (foreign) (amended)
6:38am
and there is no action, suit, proceeding, or investigation before or brought by any Governmental Agency against any of the PRC Companies on labor … no investigation of, and do not express or imply any views on, the laws of any jurisdiction other than the PRC, and we have assumed that no such other
F-1/A
EX-99.2
CNTB
Connect Biopharma Holdings Ltd
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
, or investigation before or brought by any Governmental Agency against any of the PRC Companies on labor or employment matters, except, in each case, for those … (the “Qualifications”):
Our opinions are limited to PRC Laws of general application on the date hereof. We have made no investigation of, and do not express or imply
F-3
EX-1.2
CNTB
Connect Biopharma Holdings Ltd
15 Apr 22
Shelf registration (foreign)
5:27pm
, suit, proceeding, inquiry or investigation brought by or before any legal or governmental entity now pending or, to the knowledge of the Company … of noncompliance or violation, investigation or proceedings relating to any Environmental Law against the Company or any of its subsidiaries; and (iv
F-1/A
EX-10.2
5f1ybl
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1MEF
EX-8.2
sl5pf17yuw
18 Mar 21
Registration statement to add securities to prior F-1 registration
9:02pm
F-1/A
EX-8.3
gmq98
17 Mar 21
Registration statement (foreign) (amended)
6:38am
F-1MEF
EX-8.3
6fcfh4df
18 Mar 21
Registration statement to add securities to prior F-1 registration
9:02pm
F-1/A
EX-1.1
w1xg5 y39lj
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1
EX-10.1
hvg1b6p7iy3xv1220
26 Feb 21
Registration statement (foreign)
4:56pm
DRS
EX-10.1
u64 cqgnmmqigh
17 Dec 20
Draft registration statement
12:00am
F-1/A
EX-10.3
4pc 1nsc4qlo
12 Mar 21
Registration statement (foreign) (amended)
5:02pm
F-1/A
EX-10.3
1t3y2ln05x
17 Mar 21
Registration statement (foreign) (amended)
6:38am
F-1
EX-10.11
w67bs 1obz6h30
26 Feb 21
Registration statement (foreign)
4:56pm
20-F
wtm y6vr4n2ff6p0m
31 Mar 22
Annual report (foreign)
4:33pm
F-1
zeh107jlu7roy1233ekl
26 Feb 21
Registration statement (foreign)
4:56pm
424B4
g0nhbuu 10k
19 Mar 21
Prospectus supplement with pricing info
4:49pm